Your browser doesn't support javascript.
loading
Prediction tools and risk stratification in epilepsy surgery.
Hadady, Levente; Sperling, Michael R; Alcala-Zermeno, Juan Luis; French, Jacqueline A; Dugan, Patricia; Jehi, Lara; Fabó, Dániel; Klivényi, Péter; Rubboli, Guido; Beniczky, Sándor.
  • Hadady L; Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Sperling MR; Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Alcala-Zermeno JL; Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • French JA; Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
  • Dugan P; Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
  • Jehi L; Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Fabó D; Center for Computational Life Sciences, Cleveland, Ohio, USA.
  • Klivényi P; Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Rubboli G; Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary.
  • Beniczky S; Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Epilepsia ; 65(2): 414-421, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38060351
ABSTRACT

OBJECTIVE:

This study was undertaken to conduct external validation of previously published epilepsy surgery prediction tools using a large independent multicenter dataset and to assess whether these tools can stratify patients for being operated on and for becoming free of disabling seizures (International League Against Epilepsy stage 1 and 2).

METHODS:

We analyzed a dataset of 1562 patients, not used for tool development. We applied two scales Epilepsy Surgery Grading Scale (ESGS) and Seizure Freedom Score (SFS); and two versions of Epilepsy Surgery Nomogram (ESN) the original version and the modified version, which included electroencephalographic data. For the ESNs, we used calibration curves and concordance indexes. We stratified the patients into three tiers for assessing the chances of attaining freedom from disabling seizures after surgery high (ESGS = 1, SFS = 3-4, ESNs > 70%), moderate (ESGS = 2, SFS = 2, ESNs = 40%-70%), and low (ESGS = 2, SFS = 0-1, ESNs < 40%). We compared the three tiers as stratified by these tools, concerning the proportion of patients who were operated on, and for the proportion of patients who became free of disabling seizures.

RESULTS:

The concordance indexes for the various versions of the nomograms were between .56 and .69. Both scales (ESGS, SFS) and nomograms accurately stratified the patients for becoming free of disabling seizures, with significant differences among the three tiers (p < .05). In addition, ESGS and the modified ESN accurately stratified the patients for having been offered surgery, with significant difference among the three tiers (p < .05).

SIGNIFICANCE:

ESGS and the modified ESN (at thresholds of 40% and 70%) stratify patients undergoing presurgical evaluation into three tiers, with high, moderate, and low chance for favorable outcome, with significant differences between the groups concerning having surgery and becoming free of disabling seizures. Stratifying patients for epilepsy surgery has the potential to help select the optimal candidates in underprivileged areas and better allocate resources in developed countries.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article